Alphamab Oncology Files HKEX Disclosure on Repurchase of 236,000 Shares for HKD 2.46 Million
Alphamab Oncology disclosed to the Hong Kong Stock Exchange the repurchase of 236,000 shares for HKD 2.46 million, to be held as treasury shares. This announcement was made via the Issuer Information Service on December 1, 2025.
Alphamab Oncology has filed a next day disclosure return with the Hong Kong Stock Exchange, reporting the repurchase of 236,000 shares at a total aggregate price of HKD 2,457,270. The repurchased shares will be held as treasury shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alphamab Oncology published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251201-11937707), on December 01, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)
